Similar articles

• Can medical genetics and evolutionary biology inspire drug target identification?

  Wang ZY, Fu LY, Zhang HY. Wang ZY, et al. Trends Mol Med. 2012 Feb;18(2):69-71. doi: 10.1016/j.molmed.2011.11.004. Epub 2011 Dec 13. Trends Mol Med. 2012. PMID: 22172275
• Human accelerated genome regions with value in medical genetics and drug discovery.

  Chu XY, Quan Y, Zhang HY. Chu XY, et al. Drug Discov Today. 2020 May;25(5):821-827. doi: 10.1016/j.drudis.2020.03.001. Epub 2020 Mar 7. Drug Discov Today. 2020. PMID: 32156545 Review.
• Calls grow to tap the gold mine of human genetic knockouts.

  Mullard A. Mullard A. Nat Rev Drug Discov. 2017 Jul 31;16(8):515-518. doi: 10.1038/nrd.2017.139. Nat Rev Drug Discov. 2017. PMID: 28757624 No abstract available.
• Genomics moves into the clinic.

  Webb S. Webb S. Biotechniques. 2012 Feb;52(2):73-6. doi: 10.2144/000113806. Biotechniques. 2012. PMID: 22313404 Review. No abstract available.
• Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.

  Wang H, Gu Q, Wei J, Cao Z, Liu Q. Wang H, et al. Clin Pharmacol Ther. 2015 May;97(5):451-4. doi: 10.1002/cpt.82. Epub 2015 Apr 3. Clin Pharmacol Ther. 2015. PMID: 25670647